Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept

por Kaddurah-Daouk, R, Boyle, S H, Matson, W, Sharma, S, Matson, S, Zhu, H, Bogdanov, M B, Churchill, E, Krishnan, R R, Rush, A J, Pickering, E, Delnomdedieu, M
Publicado 2011

Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo

por Kaddurah-Daouk, R, Bogdanov, M B, Wikoff, W R, Zhu, H, Boyle, S H, Churchill, E, Wang, Z, Rush, A J, Krishnan, R R, Pickering, E, Delnomdedieu, M, Fiehn, O
Publicado 2013

Sodium-dependent phosphate transporter NaPi2b as a potential predictive marker for targeted therapy of ovarian cancer

por Nurgalieva, A.K., Popov, V.E., Skripova, V.S., Bulatova, L.F., Savenkova, D.V., Vlasenkova, R.A., Safina, S.Z., Shakirova, E. Zh, Filonenko, V.V., Bogdanov, M.V., Kiyamova, R.G.
Publicado 2021

Alterations in metabolic pathways and networks in Alzheimer's disease

por Kaddurah-Daouk, R, Zhu, H, Sharma, S, Bogdanov, M, Rozen, S G, Matson, W, Oki, N O, Motsinger-Reif, A A, Churchill, E, Lei, Z, Appleby, D, Kling, M A, Trojanowski, J Q, Doraiswamy, P M, Arnold, S E
Publicado 2013